The biotech sector has been a disaster for investors over the past five years going by a 14% decline compared to an 86% gain ...

Greenyn Biotechnology Launches Insumate® mcIRBP-19 Bitter Melon Peptide, Targeting the Billion-Dollar Health Supplement ...

Clearmind Medicine shares dropped in after-hours trading following the company's announcement of a 1-for-40 reverse stock ...

A Nobel laureate, he identified an enzyme that cuts DNA, laying the groundwork for milestones in scientific research and ...

AI powers digital twins of cells/molecules, speeding early drug discovery and cutting trial-and-error work. Read more here.

Seventy-three pharmaceutical, biotechnology and medical device companies from mainland China filed for IPOs in Hong Kong this year, a review by BioWorld found. In the second half of 2025, 43 new ...

Shares of Regeneron Pharmaceuticals ( REGN 0.56%), a biotech giant, have been southbound over the past two years as the ...

The SBIO ETF has staged a remarkable comeback, outperforming despite a challenging macro backdrop and small-cap weakness.

Explore the challenges and opportunities in enhancing India's medical research ecosystem to unlock its potential for ...

Zealand Pharma A/S (Nasdaq: ZEAL) is a biotechnology company focused on advancing medicines for obesity and metabolic health. Combining more than 25 years of peptide R&D expertise with a proprietary ...

A drug launch is one of the most defining events in the pharma and biotech lifecycle. It marks the moment a therapy moves ...

Genetic medicine outfit Ensoma is halving its workforce, with most of the impacted roles related to platform research functions. The workforce reduction will affect 37 employees at the Boston biotech, ...